Cladribine for untreated or early low-grade non-Hodgkin's lymphoma.
Liliemark, J
Cladribine for untreated or early low-grade non-Hodgkin's lymphoma. [electronic resource] - Leukemia & lymphoma Aug 1998 - 573-81 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
1042-8194
10.3109/10428199809057569 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--adverse effects
Cell Transformation, Neoplastic
Cladribine--adverse effects
Disease Progression
Female
Humans
Infusions, Intravenous
Lymphoma, Non-Hodgkin--drug therapy
Lymphopenia--chemically induced
Male
Middle Aged
Platelet Count--drug effects
Survival Analysis
Thrombocytopenia--chemically induced
Treatment Outcome
Cladribine for untreated or early low-grade non-Hodgkin's lymphoma. [electronic resource] - Leukemia & lymphoma Aug 1998 - 573-81 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
1042-8194
10.3109/10428199809057569 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--adverse effects
Cell Transformation, Neoplastic
Cladribine--adverse effects
Disease Progression
Female
Humans
Infusions, Intravenous
Lymphoma, Non-Hodgkin--drug therapy
Lymphopenia--chemically induced
Male
Middle Aged
Platelet Count--drug effects
Survival Analysis
Thrombocytopenia--chemically induced
Treatment Outcome